Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis

Pediatrics

Volumn 97, Issue 4, 1996, Pages 524-528

  Farrell, Philip M ^a   Koscik, Rebecca E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Cystic fibrosis; Genotype; Infants; Newborn screening; Sweat test

Indexed keywords

CHLORIDE; PILOCARPINE;

ARTICLE; CYSTIC FIBROSIS; GENE DELETION; GENETIC ANALYSIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN SCREENING; PRIORITY JOURNAL; SWEAT TEST;

AGE FACTORS; ALLELES; BASE COMPOSITION; CHLORIDES; CODON; CYSTIC FIBROSIS; DNA; FOLLOW-UP STUDIES; GENE DELETION; GENES, REGULATOR; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFANT; INFANT, NEWBORN; IONTOPHORESIS; MUTATION; NEONATAL SCREENING; PARASYMPATHOMIMETICS; PILOCARPINE; SWEAT; TRYPSINOGEN;

EID: 0029887951     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. di Sant'Agnese PA, Darling RC, Perera GA, et al. Sweat electrolyte disturbances associated with childhood pancreatic disease. Am J Med. 1953,15:777-784
2. Anderson MP, Rich DP, Gregory RJ, Smith AE, Welsh MJ. Generation of cAMP-activated chloride currents, by expression of CFTR Science. 1991; 251:679-682
3. Gibson LE, Cooke RE A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis Pediatrics. 1959,23:545-549
4. di Sant'Agnese PA, Farrell PM. Neonatal and general aspects of cystic fibrosis. In. Young DS, Hicks JM, eds The Neonate. Current Topics in Clinical Chemistry New York. John Wiley & Sons, 1976:199-217
5. LeGrys VA, Barlow WK, Bracey A, et al. Sweat testing, sample collection and quantitative analysis. A proposed guideline. Natl Comm Clin Lab Stand 1993,13:19-21
6. di Sant'Agnese PA, Davis PB Research in cystic fibrosis N Engt J Med 1976,295:481-485
7. Shwachman H, Cluck L, Cone TE Jr, Dodge PR, Falkner F, Green M, eds. Cystic fibrosis In: Current Problems in Pediatrics Chicago, II.: Year Book Medical Publishers, Inc; 1978;8:1-72
8. Stern RC, Boal TF, Abramowsky CR, Matthews LW, Wood RE, Doershuk CF Intermediate-range sweat chloride concentration and pseudomonas bronchitis A cystic fibrosis variant with preservation of exocrine pancreatic function. JAMA 1978;239:2676-2680
9. di Sant'Agnese PA, Powell GF. The eccrine sweat detect in cystic tibrosis of the pancreas (mucoviscidosis). Ann NY Acad Sci 1962;93:555
10. Sproul A, Huang N Diagnosis of heterozygosity for cystic fibrosis by discriminatory analysis, of sweat chloride distribution J Pediatr 1966; 69 759-770
11. Sato K, Sato F Variable reduction in beta-adrenergic sweat secretion in cystic fibrosis heterozygotes. J Lab Clin Med. 1988;111:511-518
12. Boat TF, Welsh MJ, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 6th ed. New York: McGraw-Hill, Inc; 1989:2649-2680
13. Anderson CM, Freeman M. Sweat test results in normal persons of different ages compared with families with fibrocystic disease of the pancreas. Arch Dis Child. 1960;35:581-587
14. Highsmith WE, Burch LH, Zhou Z, et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations N Engl J Med. 1994;331:974-980
15. Farrell PM, Mischler EM. Newborn screening for cystic fibrosis. Adv Pediatr. 1992;39:35-70
16. FitzSimmons S. The changing epidemiology of cystic fibrosis. J Pediatr. 1993;122 1-9
17. Elian E, Shwachman H, Hendren WH Intestinal obstruction of the newborn infant. Usefulness of the sweat electrolyte test in differential diagnosis. N Engl J Med. 1961;264:13-16
18. Hammond KB, Abman SH, Sokol RJ, Accurso FJ Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. N Engl J Med. 1991;325:769-774
19. Rock MJ, Mischler EH, Farrell PM, Bruns WT, Hassemer DJ, Laessig RH. Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test Pediatr Pulmonol. 1989;6:42-48
20. Gregg RG, Wilfond BS, Farrell PM, Laxova A, Hassemer D, Mischler EH. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols. Am J Hum Genet. 1993;52:616-626
21. Rock MJ, Mischler EH, Farrell PM, et al. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels Pediatrics 1990;85:1001-1007
22. Farrell PM, Aronson RA, Hoffman G, Laessig RH. Newborn screening for cystic fibrosis in Wisconsin: first application of population-based molecular genetics testing. Wis Med J 1994;93:415-421
23. Lobeck CC. Cystic fibrosis. In. Stanbury JB, Wyngaarden JB, Fredrickson DS, eds The Metabolic Basis of Inherited Disease. 3rd ed New York: McGraw-Hill, Inc; 1972:1605-1626
24. Davis PB. Sweat chloride concentration in adults with pulmonary diseases. Am Rev Respir Dis. 1983;128.34-37
25. Wilfond BS, Farrell PM, Laxova A, Mischler E. Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis Clin Pediatr (Phila) 1994;33:2-7